Literature DB >> 728352

Comparative effects of cyclophosphamide and isophosphamide on Lewis lung carcinoma.

A Corsi, F Calabresi, C Greco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 728352      PMCID： PMC2009779          DOI： 10.1038/bjc.1978.260

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).

Authors:  P J Creaven; L M Allen; M H Cohen; R L Nelson
Journal:  Cancer Treat Rep       Date:  1976-04

2.  Unexpected toxicity in patients treated with iphosphamide.

Authors:  J J Van Dyk; H C Falkson; A M Van der Merwe; G Falkson
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

3.  [Comparison of ifosfamid with cyclophosphamide in the therapy of rat DS carcinosarcoma].

Authors:  M von Ardenne; P G Reitnauer; K Rohde
Journal:  Arch Geschwulstforsch       Date:  1971

4.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

5.  A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.

Authors:  W D DeWys
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.